Drug factory · FDA FEI 3008345655
Shanghai Desano Bio-Pharmaceutical Co., Ltd.
1479 Zhangheng Road, China (Shanghai) Pilot Free Trade Zone, China
Problems found, fixed voluntarily at FDA's last inspection, Oct 18, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
2 drug inspections on record since 2019: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Lamivudine and Zidovudine | Makes it | Shanghai Desano Bio-Pharmaceutical Co., Ltd. | 54741-102 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Oct 18, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Aug 2, 2019 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: manufacture.